Manuel Modiano
Impact in
- Oncology top 0.2%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 51
- Cancer Treatment and Pharmacology 20
- Colorectal Cancer Treatments and Studies 14
- Lung Cancer Research Studies 13
-
- Lung Cancer Treatments and Mutations 16
- Prostate Cancer Treatment and Research 7
- Co-authors
- Mace L. Rothenberg (3 shared papers)Daniel D. Von Hoff (2 shared papers)Russell K. Portenoy (2 shared papers)Ryan Nelson (2 shared papers)M. Christine Cripps (2 shared papers)Malcolm J. Moore (2 shared papers)Connie Stephens (2 shared papers)Anna Maria Storniolo (2 shared papers)
- Journals
- Journal of Clinical Oncology (34 papers)Investigational New Drugs (5 papers)Cancer (4 papers)European Journal of Cancer (4 papers)Cancer Research (3 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Manuel Modiano
87 papers receiving 6.8k citations
Manuel Modiano's Hit Papers
Peers
Comparison fields: 5 of 128
- Oncology 5.0k
- Cancer Research 1.7k
- Pulmonary and Respiratory Medicine 1.8k
- Hepatology 336
- Epidemiology 1.3k
Countries citing papers authored by Manuel Modiano
This map shows the geographic impact of Manuel Modiano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Modiano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Modiano more than expected).
Fields of papers citing papers by Manuel Modiano
This network shows the impact of papers produced by Manuel Modiano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Modiano. The network helps show where Manuel Modiano may publish in the future.
Co-authors
The 25 scholars most cited alongside Manuel Modiano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Hit paper breakdown → | 1997 | 4630 |
| 2 | 2006 | 227 | |
| 3 | 2002 | 129 | |
| 4 | 2002 | 125 | |
| 5 | 2014 | 120 | |
| 6 | 2015 | 119 | |
| 7 | 2003 | 118 | |
| 8 | 2002 | 108 | |
| 9 | 2015 | 105 | |
| 10 | 2018 | 98 | |
| 11 | Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors. | 2003 | 97 |
| 12 | 2005 | 81 | |
| 13 | 2017 | 67 | |
| 14 | 2004 | 66 | |
| 15 | 1990 | 65 | |
| 16 | 2004 | 53 | |
| 17 | 2016 | 44 | |
| 18 | 2007 | 40 | |
| 19 | 2002 | 30 | |
| 20 | 1997 | 30 |
About Manuel Modiano
Manuel Modiano is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Pathology and Forensic Medicine, having authored 87 papers that have together received 7.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (20 papers), Lung Cancer Treatments and Mutations (16 papers), Colorectal Cancer Treatments and Studies (14 papers), Lung Cancer Research Studies (13 papers), Cancer therapeutics and mechanisms (11 papers), Nausea and vomiting management (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Prostate Cancer Treatment and Research (7 papers). The work is most often cited by research in Oncology (5.0k citations), Cancer Research (1.7k citations), Pulmonary and Respiratory Medicine (1.8k citations), Hepatology (336 citations) and Epidemiology (1.3k citations). Manuel Modiano has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Mace L. Rothenberg, Daniel D. Von Hoff, Russell K. Portenoy, Ryan Nelson, M. Christine Cripps, Malcolm J. Moore, Connie Stephens, Anna Maria Storniolo, Peter G. Tarassoff and Howard A. Burris. Their work appears in journals such as Journal of Clinical Oncology, Investigational New Drugs, Cancer, European Journal of Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.